Understanding The AlphaEbeta7 Receptor (P5864)

Target Name: Integrin alphaEbeta7 receptor

NCBI ID: P5864

Integrin alphaEbeta7 receptor

Other Name(s): alphaEbeta7

Understanding The AlphaEbeta7 Receptor

The Integrin alphaEbeta7 receptor (alphaEbeta7) is a protein that is expressed in many different tissues throughout the body. It is a member of the integrin complex, which is a cell-cell adhesion system that plays a crucial role in the development and maintenance of tissues.

The alphaEbeta7 receptor is involved in many different processes in the body, including cell signaling, migration, and the regulation of inflammation. It is also potential drug target and biomarker.

One of the key functions of the alphaEbeta7 receptor is its role in cell signaling. It is involved in the regulation of cell proliferation and differentiation, as well as the regulation of cell signaling pathways that are important for many different cellular processes.

The alphaEbeta7 receptor is also involved in the regulation of cell migration. It plays a role in the migration of many different types of cells, including cancer cells. This is important because cancer cells are able to spread throughout the body and contribute to the development of many different types of diseases.

In addition to its role in cell signaling and migration, the alphaEbeta7 receptor is also involved in the regulation of inflammation. It is a key regulator of the immune response, and it is involved in the regulation of many different types of inflammation.

Despite its many important functions, the alphaEbeta7 receptor is not well understood. There are currently very few studies that have been conducted to investigate its role in any specific process. This is because it is a relatively small protein, and it is difficult to study.

However, the potential importance of the alphaEbeta7 receptor makes it a promising drug target. Researchers are currently working to develop compounds that can selectively bind to the alphaEbeta7 receptor and inhibit its activity. These compounds may be useful for the treatment of many different types of diseases, including cancer, inflammation, and immune system disorders.

In addition to its potential as a drug target, the alphaEbeta7 receptor is also a potential biomarker. Researchers are interested in using it as a diagnostic tool for many different types of diseases. This is because its levels are often elevated in the cells that are affected by these diseases, and it can be used as a indicator of the presence of these diseases.

Overall, the alphaEbeta7 receptor is a protein that is involved in many different processes in the body. It is a potential drug target and biomarker, and more research is needed to fully understand its role in the development and maintenance of tissues.

Protein Name: Integrin AlphaEbeta7 Receptor

The "Integrin alphaEbeta7 receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Integrin alphaEbeta7 receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets